NR0B2 and plasma cell myeloma: Accordingly, when patients were subdivided according to the International Myeloma Working Group uniform response criteria into “responders” (complete or very good partial response), and “non-responders” (partial or no response), only SHP-1 inactivation was significantly associated to the “responder” status.